Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma

Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma

Abstract Background Despite multiple therapeutic modalities, the overall survival of patients with gastric adenocarcinoma remains poor, especially for advanced tumor stages. Although the tyrosine kinase MerTK has shown therapeutic relevance in several tumor entities, its potential effects in gastric...

Full description

Bibliographic Details
Main Authors: Naita Maren Wirsik, Mingyi Chen, Liping He, Uraz Yasar, Justus Gaukel, Alexander Quaas, Henrik Nienhüser, Ella Leugner, Shuai Yuan, Nikolai Schleussner, Jin‐On Jung, Jadie Sue Plücker, Martin Schneider, Thomas Schmidt
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Cancer Medicine
Subjects:
chemotherapy
gastric adenocarcinoma
MerTK
survival
UNC2025
Online Access:https://doi.org/10.1002/cam4.6866

Internet

https://doi.org/10.1002/cam4.6866

Similar Items